Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 10
1967 11
1968 16
1969 14
1970 19
1971 17
1972 15
1973 7
1974 14
1975 18
1976 13
1977 16
1978 18
1979 41
1980 36
1981 31
1982 31
1983 65
1984 66
1985 66
1986 84
1987 116
1988 131
1989 165
1990 166
1991 234
1992 369
1993 368
1994 304
1995 275
1996 254
1997 264
1998 239
1999 275
2000 243
2001 269
2002 293
2003 387
2004 451
2005 494
2006 523
2007 570
2008 681
2009 750
2010 818
2011 1008
2012 1368
2013 1708
2014 1600
2015 1466
2016 1301
2017 1250
2018 1372
2019 701
2020 18
Text availability
Article attribute
Article type
Publication date

Search Results

18,382 results
Results by year
Filters applied: . Clear all
Page 1
The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects.
Cormie P, et al. Epidemiol Rev 2017 - Review. PMID 28453622
This systematic review comprehensively summarizes the available epidemiologic and randomized controlled trial evidence investigating the role of exercise in the management of cancer. Literature searches focused on determining the potential impact of exercise on 1) cancer mortality and recurrence and 2) adverse effects of cancer and its treatment. ...
This systematic review comprehensively summarizes the available epidemiologic and randomized controlled trial evidence investigating …
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
Pervaiz N, et al. Cancer 2008. PMID 18521899 Free article.
The odds ratios (OR) for local recurrence was 0.73 (95% confidence interval [CI] 0.56-0.94; P = .02) in favor of chemotherapy. ...CONCLUSIONS: This updated meta-analysis confirms the marginal efficacy of chemotherapy in localized resectable soft-tissue sarcoma with respect to local recurrence, distant recurrence, overall recurrence, and overall survival. ...
The odds ratios (OR) for local recurrence was 0.73 (95% confidence interval [CI] 0.56-0.94; P = .02) in favor of chemotherapy. …
Local recurrence after 'standard' abdominoperineal resection: do we really need ELAPE?
Xanthis A, et al. Ann R Coll Surg Engl 2018. PMID 29022795 Free PMC article.
Over a median follow up of 32 months, 20 patients developed recurrence of any type. Local recurrence occurred in five patients (two of which also had distant recurrence), of whom two had a positive circumferential resection margin (P = 0.10). Actuarial two-year local only recurrence was 3.4% and any recurrence was 17.7%. Overall five-year cancer specific survival was 77%. ...
Over a median follow up of 32 months, 20 patients developed recurrence of any type. Local recurrence occurred in five p …
An expanded landscape of human long noncoding RNA
Jiang S, et al. Nucleic Acids Res 2019. PMID 31350901 Free PMC article.
Powered by comprehensive annotation across multiple sources, RefLnc helps to pinpoint 275 novel intergenic lncRNAs correlated with sex, age or race as well as 369 novel ones associated with patient survival, clinical stage, tumor metastasis or recurrence. ...
Powered by comprehensive annotation across multiple sources, RefLnc helps to pinpoint 275 novel intergenic lncRNAs correlated with sex, age …
Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review
Kalogiannidis I, et al. J Assist Reprod Genet 2018 - Review. PMID 29737470 Free PMC article.
Although most complete hydatidiform moles (CHMs) are diploid androgenetic, a few cases of CHMs are biparental, characterised by recurrence and familial clustering. ...
Although most complete hydatidiform moles (CHMs) are diploid androgenetic, a few cases of CHMs are biparental, characterised by recurrenc
Adult Craniopharyngioma: Case Series, Systematic Review, and Meta-Analysis
Dandurand C, et al. Neurosurgery 2018. PMID 29267973
The rates of recurrence were 17%, 27%, and 45%, respectively. The risk of developing recurrence was significant for GTR vs STR (odds ratio [OR]: 0.24, 95% confidence interval [CI]: 0.15-0.38) and STR + XRT vs STR (OR: 0.20, 95% CI: 0.10-0.41). Risk of recurrence after GTR vs STR + XRT did not reach significance (OR: 0.63, 95% CI: 0.33-1.24, P = .18). CONCLUSION: This is the first and largest systematic review focusing on the rate of recurrence in adult craniopharyngioma. ...
The rates of recurrence were 17%, 27%, and 45%, respectively. The risk of developing recurrence was significant for GTR vs STR …
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.
Simard S, et al. J Cancer Surviv 2013 - Review. PMID 23475398
PURPOSE: Fear of cancer recurrence (FCR) is among the most commonly reported problems and one of the most prevalent areas of unmet needs for cancer survivors and their carers. ...
PURPOSE: Fear of cancer recurrence (FCR) is among the most commonly reported problems and one of the most prevalent areas of unmet ne …
Risk factors of early recurrence in retroperitoneal liposarcoma.
Sánchez-Hidalgo JM, et al. Cir Esp 2018. PMID 30054009
OS in the early recurrence group was 36.4 months compared with 43.2 months in the group without early recurrence (P=.011). Early recurrence was associated with a reduction in OS (HR=4.05; CI95%: 1.27-12.96; P=.018). Multifocality and microscopic positive margins R1 were associated with early recurrence. Histologic subtype, margin of resection, histologic grade and multifocality were factors associated with recurrence. ...
OS in the early recurrence group was 36.4 months compared with 43.2 months in the group without early recurrence (P=.011). Ear …
18,382 results
Jump to page
Feedback